Porton Newsletter - Jan. to Feb. 2025 Recap

Others

News 2025-07-01

Porton Selected as a Representative Company in Frost & Sullivan's "2025 China Pharmaceutical CDMO Industry Insight Blue Book"

Recently, Frost & Sullivan released the “2025 China Pharmaceutical CDMO Industry Insight Blue Book”, a comprehensive analysis of the evolution and strategic trajectory of China’s pharmaceutical Contract Development and Manufacturing Organization (CDMO) sector.

News 2025-06-20

Porton Shanghai Pudong R&D and Manufacturing Site Has Passed the EU QP Audit

Porton Pharma Solutions Ltd. (hereinafter “Porton”) is glad to announce that its Shanghai Pudong R&D and Manufacturing Site has passed the EU Qualified Person (QP) audit.

Become part of Porton' s community to access personalized insights and resources.

First name *

Last name *

E-mail *

Company *

Subscribe for the Newsletter

Porton requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and our commitment to protecting your privacy, please review our Legal Disclaimer Terms and Porton Privacy.

US: (609) 860-1300
CN: (86) 23-8608-3200

This website provides information on products tailored for a diverse audience and may include product details or information that are not readily accessible or valid in your country. Please note that we do not accept any responsibility for accessing such information in a manner that may violate any legal processes, regulations, registrations, or usage guidelines in your country of origin.

Become part of Porton' s community to access personalized insights and resources.

Submit

By clicking “Submit” you agree to our Legal Disclaimer terms and conditions and the Porton Privacy and Cookies Policy.

US: (609) 860-1300
CN: (86) 23-8608-3200